Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2024-12-31 |
2024-01-01 to 2024-12-31 |
As at 2023-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Name of reporting entity or other means of identification | — |
Pharming Group N.V.
|
— |
| Legal form of entity | — |
limited liability public company
|
— |
| Country of incorporation | — |
Netherlands
|
— |
| Principal place of business | — |
|
— |
| Description of nature of entity's operations and principal activities | — |
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
55,724,000
USD
|
— |
56,760,000
USD
|
| Disclosure of material accounting policy information [text block] | — |
|
— |